Disposition of tradable shares by Miller Josh of Exicure at 0.83 subject to Rule 16b-3
| XCUR Stock | USD 10.81 0.08 0.75% |
Slightly above 55% of Exicure's retail investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Exicure suggests that some traders are interested. Exicure's investing sentiment overview a quick insight into current market opportunities from investing in Exicure. Many technical investors use Exicure stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Exicure |
Filed transaction by Exicure Officer Chief Accounting Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Exicure Fundamental Analysis
We analyze Exicure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Exicure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Exicure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Exicure is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Exicure Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Exicure stock to make a market-neutral strategy. Peer analysis of Exicure could also be used in its relative valuation, which is a method of valuing Exicure by comparing valuation metrics with similar companies.
Peers
Exicure Related Equities
| HCWB | HCW Biologics | 7.69 | ||||
| SCPH | Scpharmaceuticals | 4.86 | ||||
| CYCC | Cyclacel Pharmaceuticals | 2.86 | ||||
| IMNN | Imunon | 1.11 | ||||
| RNXT | RenovoRx | 0.74 | ||||
| IKNA | Ikena Oncology | 0.67 | ||||
| PMVP | Pmv Pharmaceuticals | 1.39 | ||||
| DMAC | DiaMedica Therapeutics | 1.54 | ||||
| MCRB | Seres Therapeutics | 2.33 | ||||
| MIST | Milestone Pharmaceuticals | 2.48 | ||||
| PTIX | Protagenic Therapeutics | 2.63 | ||||
| TPST | Tempest Therapeutics | 3.16 | ||||
| MRKR | Marker Therapeutics | 4.17 | ||||
| ONCY | Oncolytics Biotech | 7.59 |
Additional Tools for Exicure Stock Analysis
When running Exicure's price analysis, check to measure Exicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exicure is operating at the current time. Most of Exicure's value examination focuses on studying past and present price action to predict the probability of Exicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exicure's price. Additionally, you may evaluate how the addition of Exicure to your portfolios can decrease your overall portfolio volatility.